Literature DB >> 10098275

Single-administration vaccines: controlled-release technology to mimic repeated immunizations.

J L Cleland1.   

Abstract

The most effective mechanism for the elimination of disease from society is the use of vaccinations, but these often require repeated administration. However, single-administration vaccine formulations provide the repeated administrations automatically. One approach is the development of injectable controlled-release microsphere formulations containing the vaccine antigen that is released as a pulse 1-6 months after injection. The time of the pulse is dependent upon the rate of polymer degradation, which is dictated by the polymer's composition and molecular weight. This controlled-release technology may provide complete protection against disease after a single administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098275     DOI: 10.1016/s0167-7799(98)01272-4

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  17 in total

1.  Neurons Internalize Functionalized Micron-Sized Silicon Dioxide Microspheres.

Authors:  Veronica J Wallace; Raffaello Cimbro; F Javier Rubio; Lowella V Fortuno; Julie C Necarsulmer; Pyry P Koivula; Mark J Henderson; Lindsay M DeBiase; Brandon L Warren; Brandon K Harvey; Bruce T Hope
Journal:  Cell Mol Neurobiol       Date:  2017-03-04       Impact factor: 5.046

2.  Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.

Authors:  Naihan Chen; Monica M Johnson; Michael A Collier; Matthew D Gallovic; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2018-02-02       Impact factor: 9.776

3.  Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.

Authors:  Maria P Torres; Jennifer H Wilson-Welder; Senja K Lopac; Yashdeep Phanse; Brenda Carrillo-Conde; Amanda E Ramer-Tait; Bryan H Bellaire; Michael J Wannemuehler; Balaji Narasimhan
Journal:  Acta Biomater       Date:  2011-03-23       Impact factor: 8.947

4.  Sequential release of nanoparticle payloads from ultrasonically burstable capsules.

Authors:  Stephen Kennedy; Jennifer Hu; Cathal Kearney; Hadas Skaat; Luo Gu; Marco Gentili; Herman Vandenburgh; David Mooney
Journal:  Biomaterials       Date:  2015-10-22       Impact factor: 12.479

Review 5.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

6.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Authors:  S M Sivakumar; Mohammed M Safhi; M Kannadasan; N Sukumaran
Journal:  Saudi Pharm J       Date:  2011-06-25       Impact factor: 4.330

7.  Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres.

Authors:  Weien Yuan; Zhenguo Liu
Journal:  Int J Nanomedicine       Date:  2012-01-13

Review 8.  Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases.

Authors:  Chi-Ying Lin; Shih-Jie Lin; Yi-Chen Yang; Der-Yuan Wang; Hwei-Fang Cheng; Ming-Kung Yeh
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 9.  Neutralization-Enhancing RF Antibodies for HIV Vaccines.

Authors:  Konstantin V Suslov
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

10.  Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.

Authors:  Stephany Y Tzeng; Rohiverth Guarecuco; Kevin J McHugh; Sviatlana Rose; Evan M Rosenberg; Yingying Zeng; Robert Langer; Ana Jaklenec
Journal:  J Control Release       Date:  2016-05-11       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.